The brain orexin system and almorexant in fear-conditioned startle reactions in the rat

Psychopharmacology

Volumn 223, Issue 4, 2012, Pages 465-475

  Steiner, Michel A ^a   Lecourt, Hugues ^a   Jenck, Francois ^a  

^a ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

Amygdala; Animal model; Anxiety; Benzodiazepine; Brain; Drug; Fear; Neuropeptide; Rat; Startle

Indexed keywords

ALMOREXANT; BUSPIRONE; DIAZEPAM; FLUOXETINE; NEUROPEPTIDE RECEPTOR; OREXIN; OREXIN RECEPTOR; SERTRALINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEAR; FEAR POTENTIATED STARTLE; FISCHER 344 RAT; FOREFOOT; GRIP STRENGTH; MALE; MAZE TEST; MOTOR PERFORMANCE; MUSCLE RELAXATION; NEUROMODULATION; NONHUMAN; PHOTOSTIMULATION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; STARTLE REFLEX;

ACETAMIDES; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOQUINOLINES; MALE; MAZE LEARNING; NEUROPEPTIDES; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; STARTLE REACTION;

EID: 84866741292     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2736-7     Document Type: Article

References (68)

1. Avolio E, Alo R, Carelli A, CanonacoM (2011) Amygdalar orexinergic-GABAergic interactions regulate anxiety behaviors of the Syrian golden hamster. Behav Brain Res 218:288-295
2. Baldo BA, Daniel RA, Berridge CW, Kelley AE (2003) Overlapping distributions of orexin/hypocretin-And dopamine-betahydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 464:220-237
3. Berg WK, Davis M (1984) Diazepam blocks fear-enhanced startle elicited electrically from the brainstem. Physiol Behav 32:333-336
4. Bisetti A, Cvetkovic V, Serafin M, Bayer L, Machard D, Jones BE, Muhlethaler M (2006) Excitatory action of hypocretin/orexin on neurons of the central medial amygdala. Neuroscience 142:999-1004
5. Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, Mueller C, Nayler O, van Gerven J, de Haas SL, Hess P, Qiu C, Buchmann S, Scherz M, Weller T, Fischli W, Clozel M, Jenck F (2007) Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 13:150-155
6. Brown JS, Kalish HI, Farber IE (1951) Conditioned fear as revealed by magnitude of startle response to an auditory stimulus. J Exp Psychol 41:317-328
7. Burghardt NS, Bush DE, McEwen BS, LeDoux JE (2007) Acute selective serotonin reuptake inhibitors increase conditioned fear expression: Blockade with a 5-HT(2 C) receptor antagonist. Biol Psychiatry 62:1111-1118
8. Cluderay JE, Harrison DC, Hervieu GJ (2002) Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul Pept 104:131-144
9. Commissaris RL, Fomum EA, Leavell BJ (2004) Effects of buspirone and alprazolam treatment on the startle-potentiated startle response. Depress Anxiety 19:146-151
10. Davis M (1979) Diazepam and flurazepam: Effects on conditioned fear as measured with the potentiated startle paradigm. Psychopharmacology (Berl) 62:1-7
11. Di Fabio R, Pellacani A, Faedo S, Roth A, Piccoli L, Gerrard P, Porter RA, Johnson CN, Thewlis K, Donati D, Stasi L, Spada S, Stemp G, Nash D, Branch C, Kindon L, MassagrandeM, Poffe A, Braggio S, Chiarparin E, Marchioro C, Ratti E, Corsi M (2011) Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders. Bioorg Med Chem Lett 21:5562-5567
12. Dietrich H, Jenck F (2010) Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant. Psychopharmacology (Berl) 212:145-154
13. Dun NJ, Le Dun S, Chen CT, Hwang LL, Kwok EH, Chang JK (2000) Orexins: A role in medullary sympathetic outflow. Regul Pept 96:65-70
14. Eison AS, Temple DL Jr (1986) Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Am J Med 80:1-9
15. Fendt M, Fanselow MS (1999) The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev 23:743-760
16. Furlong TM, Vianna DM, Liu L, Carrive P (2009) Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal. Eur J Neurosci 30:1603-1614
17. Grillon C (2008) Models and mechanisms of anxiety: Evidence from startle studies. Psychopharmacology (Berl) 199:421-437
18. Grillon C, Baas J (2003) A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol 114:1557-1579
19. Grillon C, Morgan CA 3rd (1999) Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. J Abnorm Psychol 108:134-142
20. Grillon C, Ameli R, Goddard A, Woods SW, Davis M (1994) Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry 35:431-439
21. Grillon C, Pellowski M, Merikangas KR, Davis M (1997) Darkness facilitates the acoustic startle reflex in humans. Biol Psychiatry 42:453-460
22. Grillon C, Levenson J, Pine DS (2007) A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: A fear-potentiated startle study. Neuropsychopharmacology 32:225-231
23. Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA (2001) Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103:777-797
24. Hijzen TH, Slangen JL (1989) Effects of midazolam, DMCM and lindane on potentiated startle in the rat. Psychopharmacology (Berl) 99:362-365
25. Hitchcock JM, Davis M (1987) Fear-potentiated startle using an auditory conditioned stimulus: Effect of lesions of the amygdala. Physiol Behav 39:403-408
26. Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S, Traskman-Bendz L, Goddard AW, Brundin L, Shekhar A (2010) A key role for orexin in panic anxiety. Nat Med 16:111-115
27. Johnson PL, Samuels BC, Fitz SD, Lightman SL, Lowry CA, Shekhar A (2012) Activation of the orexin 1 receptor is a critical component of CO(2)-mediated anxiety and hypertension but not bradycardia. Neuropsychopharmacology doi:10.1038/npp.2012.38
28. Joordens RJ, Hijzen TH, Peeters BW, Olivier B (1996) Fearpotentiated startle response is remarkably similar in two laboratories. Psychopharmacology (Berl) 126:104-109
29. Kayaba Y, Nakamura A, Kasuya Y, Ohuchi T, Yanagisawa M, Komuro I, Fukuda Y, Kuwaki T (2003) Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 285:R581-R593
30. Kehne JH, Cassella JV, DavisM (1988) Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. Psychopharmacology (Berl) 94:8-13
31. Khatami R, Birkmann S, Bassetti CL (2007) Amygdala dysfunction in narcolepsy-cataplexy. J Sleep Res 16:226-229
32. Kuwaki T, Li A, Nattie E (2010) State-dependent central chemoreception: A role of orexin. Respir Physiol Neurobiol 173:223-229
33. Leaton RN, Cranney J (1990) Potentiation of the acoustic startle response by a conditioned stimulus paired with acoustic startle stimulus in rats. J Exp Psychol Anim Behav Process 16:279-287
34. Li Y, Li S, Wei C, Wang H, Sui N, Kirouac GJ (2010) Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats. Psychopharmacology (Berl) 212:251-265
35. Lissek S, Biggs AL, Rabin SJ, Cornwell BR, Alvarez RP, Pine DS, Grillon C (2008) Generalization of conditioned fear-potentiated startle in humans: Experimental validation and clinical relevance. Behav Res Ther 46:678-687
36. Lu XY, Bagnol D, Burke S, Akil H, Watson SJ (2000) Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 37:335-344
37. Mansbach RS, Geyer MA (1988) Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligands. Eur J Pharmacol 156:375-383
38. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435:6-25
39. McQueen DA, Overstreet DH, Ardayfio PA, Commissaris RL (2001) Acoustic startle, conditioned startle potentiation and the effects of 8-OH-DPAT and buspirone in rats selectively bred for differences in 8-OH-DPAT-induced hypothermia. Behav Pharmacol 12:509-516
40. Missig G, Ayers LW, Schulkin J, Rosen JB (2010) Oxytocin reduces background anxiety in a fear-potentiated startle paradigm. Neuropsychopharmacology 35:2607-2616
41. Morgan CA 3rd, Grillon C, Southwick SM, Davis M, Charney DS (1995) Fear-potentiated startle in posttraumatic stress disorder. Biol Psychiatry 38:378-385
42. Nakamura S, Tsumori T, Yokota S, Oka T, Yasui Y (2009) Amygdaloid axons innervate melanin-concentrating hormone-And orexincontaining neurons in the mouse lateral hypothalamus. Brain Res 1278:66-74
43. Nicolas LB, Prinssen EP (2006) Social approach-Avoidance behavior of a high-Anxiety strain of rats: Effects of benzodiazepine receptor ligands. Psychopharmacology (Berl) 184:65-74
44. Nollet M, Gaillard P, Minier F, Tanti A, Belzung C, Leman S (2011) Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology 61:336-346
45. Panhelainen AE, Korpi ER (2012) Evidence for a role of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: A c-Fos study. Pharmacol Biochem Behav 101:115-124
46. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996-10015
47. Pole N, Neylan TC, Best SR, Orr SP, Marmar CR (2003) Fearpotentiated startle and posttraumatic stress symptoms in urban police officers. J Trauma Stress 16:471-479
48. Ponz A, Khatami R, Poryazova R, Werth E, Boesiger P, Schwartz S, Bassetti CL (2010) Reduced amygdala activity during aversive conditioning in human narcolepsy. Ann Neurol 67:394-398
49. Rainero I, Ostacoli L, Rubino E, Gallone S, Picci LR, Fenoglio P, Negro E, Rosso C, De Martino P, De Marchi M, Furlan PM, Pinessi L (2011) Association between major mood disorders and the hypocretin receptor 1 gene. J Affect Disord 130:487-491
50. Risbrough VB, Brodkin JD, Geyer MA (2003) GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice. Neuropsychopharmacology 28:654-663
51. Sakamoto F, Yamada S, Ueta Y (2004) Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: Possible involvement of central orexins on stressactivated central CRF neurons. Regul Pept 118:183-91
52. Sakurai T (2007) The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8:171-81
53. Sakurai T, Nagata R, Yamanaka A, Kawamura H, Tsujino N, Muraki Y, Kageyama H, Kunita S, Takahashi S, Goto K, Koyama Y, Shioda S, Yanagisawa M (2005) Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron 46:297-308
54. Schmitt O, Usunoff KG, Lazarov NE, Itzev DE, Eipert P, Rolfs A, Wree A (2011) Orexinergic innervation of the extended amygdala and basal ganglia in the rat. Brain Struct Funct 217:233-256
55. Scott MM, Marcus JN, Pettersen A, Birnbaum SG, Mochizuki T, Scammell TE, Nestler EJ, Elmquist JK, Lutter M (2011) Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav Brain Res 222:289-294
56. Shahid IZ, Rahman AA, Pilowsky PM (2011) Orexin A in rat rostral ventrolateral medulla is pressor, sympathoexcitatory, increases barosensitivity and attenuates the somatosympathetic reflex. Br J Pharmacol. doi:10.1111/j.1476-5381.2011.01694.x
57. Sinclair LI, Christmas DM, Hood SD, Potokar JP, Robertson A, Isaac A, Srivastava S, Nutt DJ, Davies SJ (2009) Antidepressantinduced jitteriness/anxiety syndrome: Systematic review. Br J Psychiatry 194:483-490
58. Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG (2006) Orexins in the regulation of the hypothalamic-pituitary-Adrenal axis. Pharmacol Rev 58:46-57
59. Steiner MA, Lecourt H, Rakotoariniaina A, Jenck F (2011a) Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat. Behav Brain Res 221:34-42
60. Steiner MA, Lecourt H, Strasser DS, Brisbare-Roch C, Jenck F (2011b) Differential effects of the dual orexin receptor antagonist almorexant and the GABA(A)-Alpha1 receptor modulator zolpidem, alone or combined with ethanol, on motor performance in the rat. Neuropsychopharmacology 36:848-856
61. Suzuki M, Beuckmann CT, Shikata K, Ogura H, Sawai T (2005) Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res 1044:116-121
62. Tallman JF, Paul SM, Skolnick P, Gallager DW (1980) Receptors for the age of anxiety: Pharmacology of the benzodiazepines. Science 207:274-281
63. Walker DL, Davis M (1997a) Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biol Psychiatry 42:461-471
64. Walker DL, Davis M (1997b) Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J Neurosci 17:9375-9383
65. Winslow JT, Noble PL, Davis M (2007) Modulation of fearpotentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone. Biol Psychiatry 61:389-395
66. Yoshida K, McCormack S, Espana RA, Crocker A, Scammell TE (2006) Afferents to the orexin neurons of the rat brain. J Comp Neurol 494:845-861
67. Zhang W, Zhang N, Sakurai T, Kuwaki T (2009) Orexin neurons in the hypothalamus mediate cardiorespiratory responses induced by disinhibition of the amygdala and bed nucleus of the stria terminalis. Brain Res 1262:25-37
68. Zhao Z, Yang Y, Walker DL, Davis M (2009) Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle. Neuropsychopharmacology 34:331-340